| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;69:1448-1454
© 2000 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, The General Hospital, Southampton, United Kingdom
Address reprint requests to Dr Monro, Department of Cardiac Surgery, The General Hospital, Tremona Rd, Southampton SO16 6YD, UK
e-mail: monro1711{at}aol.com
Background. The purpose of this study was to describe a single unit experience in the surgical treatment of active culture-positive endocarditis and identify determinants of early and late outcome.
Patients and Methods. One hundred eighteen consecutive patients with positive blood culture up to 3 weeks before operation (or positive valve culture) and macroscopic evidence of lesions typical for endocarditis, undergoing operation between January 1973 and December 1996 in Southampton, were evaluated. The aortic valve was infected in 53 (48.9%), the mitral in 46 (39%), both aortic and mitral in 12 (10.1%), the tricuspid in 4 (3.9%), and the pulmonary valve in 3 (2.5%). Native valve endocarditis was present in 83 (70.3%) and prosthetic valve endocarditis in 35 (29.7%). Streptococci and staphylococci were the most common pathogens. Mean follow-up was 5.6 years (range, 0 to 25 years).
Results. Operative mortality was 7.6% (9 patients). Endocarditis recurred in 8 (6.7%). A reoperation was required in 12 (10.2%). There was 24 late deaths, 17 of them cardiac. Actuarial freedom from recurrent endocarditis, reoperation, late cardiac death, and long-term survival at 10 years were 85.9%, 87.2%, 85.2%, and 73.1%, respectively. On multiple regression analysis the following were independent adverse predictors: pulmonary edema (p = 0.007) and impaired left ventricular function (p = 0.02) for operative mortality; prosthetic valve endocarditis (p = 0.01) for recurrent infection; myocardial invasion by the infection (p = 0.01) and reoperation (p = 0.04) for late cardiac death; and coagulase-negative staphylococcus (p = 0.02), annular abscess (p = 0.02), and longer intensive care unit stay (p = 0.02) for long-term survival.
Conclusions. Operation for active culture-positive endocarditis carries an acceptable mortality. Freedom from recurrent infection, reoperation, and long-term survival are satisfactory. In our data, patients’ hemodynamic status at operation was the major determinant of operative mortality. Prosthetic valve endocarditis, coagulase-negative staphylococcus, and annular or myocardial infectious invasion were the critical adverse determinants of late outcome.
This article has been cited by other articles:
|
|
 |
|
  2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Musci, H. Siniawski, M. Pasic, Y. Weng, A. Loforte, S. Kosky, C. Yankah, and R. Hetzer Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh(R) stentless bioprosthesis Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 410 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I M Tleyjeh, J M Steckelberg, G Georgescu, H M K Ghomrawi, T L Hoskin, F B Enders, F Mookadam, W C Huskins, W R Wilson, and L M Baddour The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis Heart, July 1, 2008; 94(7): 892 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Liao, D F Kong, Z Samad, P A Pappas, J G Jollis, S S Lin, A Wang, V G Fowler Jr, V H Chu, D J Sexton, et al. Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis Heart, May 1, 2008; 94(5): e18 - e18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. David Surgical Treatment of Aortic Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 949 - 956. [Full Text]
|
|
|
|
 |
|
 G. Nucifora, L. P. Badano, P. Viale, P. Gianfagna, G. Allocca, D. Montanaro, U. Livi, and P. M. Fioretti Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge Eur. Heart J., October 1, 2007; 28(19): 2307 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Colli, R. Campodonico, and T. Gherli Early Switch From Vancomycin to Oral Linezolid for Treatment of Gram-Positive Heart Valve Endocarditis Ann. Thorac. Surg., July 1, 2007; 84(1): 87 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shibata, Y. Sasaki, H. Hirai, T. Fukui, M. Hosono, and S. Suehiro Early surgery for hospital-acquired and community-acquired active infective endocarditis Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 354 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lopez, A. Revilla, I. Vilacosta, E. Villacorta, C. Gonzalez-Juanatey, I. Gomez, M. J. Rollan, and J. A. San Roman Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis Eur. Heart J., March 2, 2007; 28(6): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmidtke, G. Dahmen, and H.-H. Sievers Subcoronary Ross Procedure in Patients With Active Endocarditis Ann. Thorac. Surg., January 1, 2007; 83(1): 36 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
|
|
B D Prendergast The changing face of infective endocarditis Heart, July 1, 2006; 92(7): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Doukas, M Oc, C Alexiou, A W Sosnowski, N J Samani, and T J Spyt Mitral valve repair for active culture positive infective endocarditis Heart, March 1, 2006; 92(3): 361 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mahesh, G. Angelini, M. Caputo, X. Y. Jin, and A. Bryan Prosthetic Valve Endocarditis Ann. Thorac. Surg., September 1, 2005; 80(3): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Thuny, G. Disalvo, O. Belliard, J.-F. Avierinos, V. Pergola, V. Rosenberg, J.-P. Casalta, J. Gouvernet, G. Derumeaux, D. Iarussi, et al. Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study Circulation, July 5, 2005; 112(1): 69 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murashita, H. Sugiki, Y. Kamikubo, and K. Yasuda Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1104 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Karchmer, D. F. Torchiana, C. U. Chae, N. A. Afridi, and S. L. Houser Case 29-2004 - A 75-Year-Old Woman with Acute Onset of Chest Pain Followed by Fever N. Engl. J. Med., September 16, 2004; 351(12): 1240 - 1248. [Full Text] [PDF]
|
|
|
|
|
|
B. Iung, J. Rousseau-Paziaud, B. Cormier, E. Garbarz, O. Fondard, E. Brochet, C. Acar, J.-P. Couetil, U. Hvass, and A. Vahanian Contemporary results of mitral valve repair for infective endocarditis J. Am. Coll. Cardiol., February 4, 2004; 43(3): 386 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hasbun, H. R. Vikram, L. A. Barakat, J. Buenconsejo, and V. J. Quagliarello Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality JAMA, April 16, 2003; 289(15): 1933 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. V. Granowitz and D. L. Longworth Risk Stratification and Bedside Prognostication in Infective Endocarditis JAMA, April 16, 2003; 289(15): 1991 - 1993. [Full Text] [PDF]
|
|
|
|
|
|
T. E. David Surgical Treatment of Aortic Valve Endocarditis Card. Surg. Adult, January 1, 2003; 2(2003): 857 - 866. [Full Text]
|
|
|
|
|
|
S. Beholz, H. Hotz, J. Grosse, and W. Konertz Biventricular assist device in extreme anorexia nervosa Interactive CardioVascular and Thoracic Surgery, September 1, 2002; 1(1): 35 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R O M Netzer, S C Altwegg, E Zollinger, M Tauber, T Carrel, and C Seiler Infective endocarditis: determinants of long term outcome Heart, July 1, 2002; 88(1): 61 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Management of infective endocarditis DTB, April 1, 2002; 40(4): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Alexiou, S. M. Langley, P. Charlesworth, M. P. Haw, S. A. Livesey, and J. L. Monro Aortic root replacement in patients with Marfan's syndrome: the Southampton experience Ann. Thorac. Surg., November 1, 2001; 72(5): 1502 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Seipelt, J. F. Vazquez-Jimenez, I. M. Seipelt, A. Franke, K. Chalabi, F. A. Schoendube, and B. J. Messmer The St. Jude ""Silzone"" valve: midterm results in treatment of active endocarditis Ann. Thorac. Surg., September 1, 2001; 72(3): 758 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Novick Invited commentary Ann. Thorac. Surg., January 1, 2001; 71(1): 104 - 104. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
